RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial

RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial

Abstract Background With the aging population, the prevalence and incidence of cerebrovascular disease will continue to rise, as well as the number of individuals with vascular cognitive impairment/dementia (VCID). No specific FDA-approved treatments for VCID exist. Although clinical evidence suppor...

Full description

Bibliographic Details
Main Authors: Heba A. Ahmed, Tauheed Ishrat, Bindu Pillai, Abdelrahman Y. Fouda, Mohammed A. Sayed, Wael Eldahshan, Jennifer L. Waller, Adviye Ergul, Susan C. Fagan
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Journal of Neuroinflammation
Subjects:
Angiotensin modulators
Cognitive-impairment
Hypertension
Stroke
Online Access:http://link.springer.com/article/10.1186/s12974-018-1262-x

Internet

http://link.springer.com/article/10.1186/s12974-018-1262-x

Similar Items